Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.98 USD | +7.00% | +7.74% | -4.37% |
Apr. 09 | Cantor Fitzgerald Initiates Structure Therapeutics at Overweight Rating With $65 Price Target | MT |
Mar. 21 | ADRs Edge Higher; Lufax Climbs Almost 46% | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 28.57M | Capitalization | 1.7B |
---|---|---|---|---|---|
Net income 2024 * | -127M | Net income 2025 * | -112M | EV / Sales 2024 * | - |
Net cash position 2024 * | 345M | Net cash position 2025 * | 150M | EV / Sales 2025 * | 54.2 x |
P/E ratio 2024 * |
-37.9
x | P/E ratio 2025 * |
-36.2
x | Employees | 93 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.06% |
1 day | +7.00% | ||
1 week | +7.74% | ||
Current month | -9.05% | ||
1 month | -9.79% | ||
3 months | -7.52% | ||
6 months | -42.35% | ||
Current year | -4.37% |
Managers | Title | Age | Since |
---|---|---|---|
Raymond Stevens
FOU | Founder | 60 | 19-01-31 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 19-01-31 |
Ying Li Ma
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Tetlow
BRD | Director/Board Member | 64 | 22-03-28 |
Ted Love
BRD | Director/Board Member | 65 | 23-08-02 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 22-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 38.98 | +7.00% | 396,030 |
24-04-24 | 36.43 | +0.94% | 222,956 |
24-04-23 | 36.09 | +0.19% | 424,016 |
24-04-22 | 36.02 | -0.94% | 558,252 |
24-04-19 | 36.36 | +0.50% | 383,323 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.37% | 1.7B | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- GPCR Stock